Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients

BACKGROUND: Mortality after myocardial infarction (MI) among patients undergoing dialysis is high. However, studies investigating the use of secondary prevention medications after MI and clinical outcomes in dialysis patients are lacking. This study aimed to examine the association of the number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ting-Yun, Hsieh, Tsung-Han, Hung, Szu-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613425/
https://www.ncbi.nlm.nih.gov/pubmed/36325012
http://dx.doi.org/10.1093/ckj/sfac170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613425/
https://www.ncbi.nlm.nih.gov/pubmed/36325012
http://dx.doi.org/10.1093/ckj/sfac170

Ejemplares similares